Developer docs
API playgroundTry for free, no card

Search company profiles

USC/Norris Cancer Hospital

Full company profile

uuid000vqgb

Namestring
USC/Norris Cancer Hospital
Legal namestring
USC Norris Comprehensive Cancer Center
Company typeenum
Private
Founded yearint
1973
Descriptiontext

USC Norris Comprehensive Cancer Center, established in 1973 and designated as an NCI Comprehensive Cancer Center in 1977, operates as an integrated cancer research, treatment, and prevention platform within the University of Southern California's Keck School of Medicine. The center runs a 60-bed inpatient hospital at 1441 Eastlake Avenue in Los Angeles and delivers outpatient cancer care through nine additional locations across Southern California, including Irvine, Newport Beach, Buena Park, and Koreatown. Its research enterprise spans five major programs — Tumor Immunology & Microenvironment, Epigenetic Regulation in Cancer, Translational and Clinical Sciences, Cancer Epidemiology, and Cancer Control Research — supported by eight shared resource cores covering Flow Cytometry, Liquid Biopsy, Molecular Genomics, Translational Pathology, Data Science, Population Research, Preclinical Models, and Glass Wash/Autoclave facilities. The center employs 250+ physicians and scientists, with 200 faculty members spanning 42 departments and 7 USC schools, and conducts 150+ active oncology clinical trials.

The business model is a nonprofit academic medical center revenue mix: clinical patient care delivered through Keck Medicine of USC; federal research funding including NCI P30 cancer center support grants, program project grants, and training grants; and philanthropic donations across individual, foundation, corporate, estate, and planned giving channels. Patient acquisition relies on healthcare provider referrals, direct appointment requests, clinical trial recruitment, and an extensive community outreach footprint including the IMPACT Program, Promotores contra el Cancer, and the NCI National Outreach Network Community Health Educator program targeting underserved populations in Los Angeles County. Specialized programs include the Adolescent and Young Adult Cancer Program (with Children's Hospital Los Angeles and LA County Hospital), the Eileen McGeever Breast Cancer Survivorship Program, the Center for Cancer Drug Development, and the Ralph Lauren Center for Cancer Prevention.

As one of the original NCI-designated comprehensive cancer centers with ~48 years of designation, USC Norris holds strong institutional positioning in the U.S. cancer care market, recently recognized in the 2025-26 U.S. News & World Report Best Hospitals survey. It is governed by USC's Board of Trustees and operated through the Keck School of Medicine under executive leadership including Director Dr. Caryn Lerman, with no private equity, venture, or public-market ownership.

Short descriptiontext

USC Norris Comprehensive Cancer Center is an NCI-designated nonprofit academic cancer center within USC's Keck School of Medicine that delivers integrated cancer research, inpatient and outpatient clinical care, and 150+ clinical trials to patients across Southern California.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersLos Angeles, United States
HQ citystring
Los Angeles
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices9 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cancer treatment services, clinical oncology trials, cancer research programs, patient cancer care, community cancer outreach
Industry5 codes
1Oncology & Cancer Specialty Hospitals
CodeHLAFAHACPrimaryYes
2Hospital-Integrated Cancer Centers (Acute Oncology Programs)
CodeHLAFAAAMPrimaryNo
3Ambulatory Oncology Centers (Outpatient Chemo/Radiation)
CodeHLAFABAIPrimaryNo
4Medical Oncology
CodeHLAKAFABPrimaryNo
5Surgical Oncology
CodeHLAKAFAGPrimaryNo
NAICS code2 codes
  • Specialty (except Psychiatric and Substance Abuse) Hospitals622310
  • Other Outpatient Care Centers62149
SIC code2 codes
  • Services-Hospitals8060
  • Services-Specialty Outpatient Facilities, Nec8093
Product category
Oncology Hospital Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Patient Care Services
TypeSubscription Recurring
Description

Clinical care services provided to cancer patients including treatment, diagnostics, and survivorship care at USC Norris Cancer Hospital and outpatient facilities.

uscnorriscancer.usc.edu
2Research Grants and Funding
TypeProfessional Services
Description

NCI-designated cancer center receives federal research grants including P30 cancer center support grants, program project grants, and training grants.

uscnorriscancer.usc.edu
3Philanthropic Donations
TypeLicensing Royalties
Description

Donations from individuals, foundations, and corporations supporting cancer research and patient care. Multiple giving options including online, phone, mail, matching gifts, donor advised funds, wire transfers, stocks/securities, IRA charitable rollovers, estate/planned gifts, and cy pres awards.

Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1Hospital pricing varies based on services provided
ModelSubscriptionBilling cadenceMonthly
Notes

Quote-based / Not publicly disclosed. Price transparency information available through hospitalpricedisclosure.com

keckmedicine.org
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

USC Norris Cancer Hospital, part of the USC Norris Comprehensive Cancer Center, delivers inpatient and outpatient cancer care through a 60-bed hospital and multiple outpatient locations across Southern California. As an NCI-designated Comprehensive Cancer Center, it also runs more than 150 active oncology clinical trials and operates five interdisciplinary research programs backed by shared resource cores (flow cytometry, liquid biopsy, molecular genomics, translational pathology, data science, population research, and preclinical models).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 48 years as an NCI-designated comprehensive cancer center
+2 more records
Product overview1 text field

USC Norris Comprehensive Cancer Center is an NCI-designated Comprehensive Cancer Center that operates as a single integrated platform offering cancer research, clinical care, clinical trials, and community outreach. The organization provides five major research programs (Tumor Immunology & Microenvironment, Epigenetic Regulation in Cancer, Translational and Clinical Sciences, Cancer Epidemiology, Cancer Control Research) supported by eight shared resource cores (Flow Cytometry, Liquid Biopsy, Molecular Genomics, Translational Pathology, Data Science, Population Research, Preclinical Models, Glass Wash/Autoclave). Patient care services are delivered through Keck Medicine of USC, while specialized programs include the Cancer Navigator, Center for Cancer Drug Development, Breast Cancer Survivorship Program, AYA Cancer Program, and NON-CHE Program for community health education. Additional support services include biorepositories, the Jennifer Diamond Cancer Resource Library, and various community wellness programs like Trojans Adelante.

Product and service2 records
1Patient Care Services
CategoryCancer Treatment Services
Description

Personalized, patient-centered cancer care including treatment, diagnostics, and survivorship support delivered through the 60-bed USC Norris Cancer Hospital and outpatient locations for individual cancer patients.

2Clinical Trials Program
Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership15 partners
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2019-01-01
Description

Partnered in organizing the inaugural bilingual Community Cancer Conference on Innovative Research and Precision Oncology Treatments.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2019-01-01
Description

Partnered with USC Norris and Tower Cancer Research Foundation for the Community Cancer Conference on Innovative Research and Precision Oncology Treatments.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2019-01-01
Description

Community partner for the inaugural Community Cancer Conference supporting underserved patient community in Los Angeles.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2019-01-01
Description

Partner in the USC Adelante/A Tu Salud Food Distribution Partnership Program addressing food insecurity for patients and community members.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2019-01-01
Description

Partner in food distribution program providing food 5 days a week at YMCA Weingart in Boyle Heights for individuals facing food insecurity.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2019-01-01
Description

Partner in expanded food distribution program during COVID-19 pandemic.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2019-01-01
Description

Partner in expanded food distribution program during COVID-19 pandemic.

8Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2018-01-01
Description

NCI-funded partnership between USC Norris, University of Florida, and Florida A&M University addressing cancer disparities with focus on prostate and pancreatic cancer among African Americans and Latinos. Trains URM faculty and graduate/post-doctoral trainees.

uscnorriscancer.usc.edu
9Clinica Oscar Romero
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2016-01-01
Description

Community health partner for the C4-SPA4 Promotores Outreach Program providing free cancer education to approximately 600 residents annually.

uscnorriscancer.usc.edu
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2013-01-01
Description

Collaborative partner in the Adolescent and Young Adult (AYA) Cancer Program, representing a collaboration between USC Norris, USC Norris Cancer Hospital, CHLA, and Los Angeles County Hospital.

11Los Angeles County Hospital
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2013-01-01
Description

Partner in the Adolescent and Young Adult (AYA) Cancer Program collaboration.

uscnorriscancer.usc.edu
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Community-based cancer prevention center providing services to local communities as part of USC Norris outreach efforts.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaborative network of cancer research institutions sharing data and accelerating discoveries through coordinated research efforts.

14Jennifer Diamond Foundation
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Foundation that funded the Patient Education and Outreach Center and Jennifer Diamond Cancer Resource Library at USC Norris, created to help others by providing resources to cancer patients and families.

uscnorriscancer.usc.edu
15National Outreach Network (NON)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

NCI-supported program providing community health educators to deliver HPV education and clinical trial awareness workshops in Los Angeles County.

uscnorriscancer.usc.edu
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

NCI-designated Comprehensive Cancer Center with a major hospital, clinical trials, and research programs in the greater Los Angeles market — a direct competitor for patients, faculty, and trial sponsorship.

TypeDirect peer
Description

NCI-designated Comprehensive Cancer Center at Stanford with comparable academic medical-center structure, translational research programs, and clinical trial portfolio in California.

TypeBroad incumbent
Description

NCI-designated cancer center affiliated with UW Medicine with major research programs in immunotherapy and translational sciences; comparable in research depth and clinical trial pipeline.

TypeDirect peer
Description

NCI-designated Comprehensive Cancer Center at UCLA, also located in Los Angeles and offering overlapping research programs, clinical trials, and inpatient/outpatient cancer services to a similar patient base in Southern California.

TypeDirect peer
Description

NCI-designated Comprehensive Cancer Center operating a dedicated cancer hospital, research programs, and clinical trials; a structurally similar standalone academic cancer center for benchmarking scale and operations.

TypeBroad incumbent
Description

Largest standalone NCI-designated cancer center with an extensive clinical trials portfolio and specialty oncology hospital; a national benchmark peer for translational research and clinical operations.

TypeDirect peer
Description

NCI-designated Comprehensive Cancer Center at Northwestern; the CAO at USC Norris previously held senior academic administration positions at Northwestern, providing a direct operational and structural comparison point.

TypeBroad incumbent
Description

Large Los Angeles academic medical center operating a cancer program with hospital beds, outpatient oncology, and clinical research; competes for the same regional patient base across a broader service portfolio.

TypeDirect peer
Description

NCI-designated Comprehensive Cancer Center at UC San Diego with parallel research programs (immunology, genomics), clinical trials, and community outreach; the CAO at USC Norris previously held a senior role here.

TypeBroad incumbent
Description

NCI-designated Comprehensive Cancer Center with the largest cancer hospital bed count and trial volume in the US; senior Norris leadership previously worked at MD Anderson, and it represents the scale benchmark.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

USC/Norris Cancer Hospital

Oncology Hospital Servicesuscnorriscancer.usc.edu

USC Norris Comprehensive Cancer Center is an NCI-designated nonprofit academic cancer center within USC's Keck School of Medicine that delivers integrated cancer research, inpatient and outpatient clinical care, and 150+ clinical trials to patients across Southern California.

What USC/Norris Cancer Hospital does

USC Norris Comprehensive Cancer Center, established in 1973 and designated as an NCI Comprehensive Cancer Center in 1977, operates as an integrated cancer research, treatment, and prevention platform within the University of Southern California's Keck School of Medicine. The center runs a 60-bed inpatient hospital at 1441 Eastlake Avenue in Los Angeles and delivers outpatient cancer care through nine additional locations across Southern California, including Irvine, Newport Beach, Buena Park, and Koreatown. Its research enterprise spans five major programs — Tumor Immunology & Microenvironment, Epigenetic Regulation in Cancer, Translational and Clinical Sciences, Cancer Epidemiology, and Cancer Control Research — supported by eight shared resource cores covering Flow Cytometry, Liquid Biopsy, Molecular Genomics, Translational Pathology, Data Science, Population Research, Preclinical Models, and Glass Wash/Autoclave facilities. The center employs 250+ physicians and scientists, with 200 faculty members spanning 42 departments and 7 USC schools, and conducts 150+ active oncology clinical trials.

The business model is a nonprofit academic medical center revenue mix: clinical patient care delivered through Keck Medicine of USC; federal research funding including NCI P30 cancer center support grants, program project grants, and training grants; and philanthropic donations across individual, foundation, corporate, estate, and planned giving channels. Patient acquisition relies on healthcare provider referrals, direct appointment requests, clinical trial recruitment, and an extensive community outreach footprint including the IMPACT Program, Promotores contra el Cancer, and the NCI National Outreach Network Community Health Educator program targeting underserved populations in Los Angeles County. Specialized programs include the Adolescent and Young Adult Cancer Program (with Children's Hospital Los Angeles and LA County Hospital), the Eileen McGeever Breast Cancer Survivorship Program, the Center for Cancer Drug Development, and the Ralph Lauren Center for Cancer Prevention.

As one of the original NCI-designated comprehensive cancer centers with ~48 years of designation, USC Norris holds strong institutional positioning in the U.S. cancer care market, recently recognized in the 2025-26 U.S. News & World Report Best Hospitals survey. It is governed by USC's Board of Trustees and operated through the Keck School of Medicine under executive leadership including Director Dr. Caryn Lerman, with no private equity, venture, or public-market ownership.

USC/Norris Cancer Hospital firmographics

Firmographics
Name
USC/Norris Cancer Hospital
Legal name
USC Norris Comprehensive Cancer Center
Website
https://uscnorriscancer.usc.edu
Company type
Private
Founded year
1973
Operating status
Operating
Headcount range
101–250 employees
Short description
USC Norris Comprehensive Cancer Center is an NCI-designated nonprofit academic cancer center within USC's Keck School of Medicine that delivers integrated cancer research, inpatient and outpatient clinical care, and 150+ clinical trials to patients across Southern California.
Ownership category
akta.pro rank

USC/Norris Cancer Hospital industry classification

Industry
Product category
Oncology Hospital Services
NAICS
Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Other Outpatient Care Centers (62149)
SIC
Services-Hospitals (8060), Services-Specialty Outpatient Facilities, Nec (8093)
akta.pro primary industry
Oncology & Cancer Specialty Hospitals (HLAFAHAC)
akta.pro secondary industries
Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM), Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Medical Oncology (HLAKAFAB), Surgical Oncology (HLAKAFAG)

Keywords

  • Cancer treatment services
  • Clinical oncology trials
  • Cancer research programs
  • Patient cancer care
  • Community cancer outreach

Where USC/Norris Cancer Hospital is headquartered

Location

Headquarters

HQ city
Los Angeles
HQ country
United States
HQ region
North America

Offices9 records

Markets served

USC/Norris Cancer Hospital business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Patient Care Services: Clinical care services provided to cancer patients including treatment, diagnostics, and survivorship care at USC Norris Cancer Hospital and outpatient facilities.
  2. Research Grants and Funding: NCI-designated cancer center receives federal research grants including P30 cancer center support grants, program project grants, and training grants.
  3. Philanthropic Donations: Donations from individuals, foundations, and corporations supporting cancer research and patient care. Multiple giving options including online, phone, mail, matching gifts, donor advised funds, wire transfers, stocks/securities, IRA charitable rollovers, estate/planned gifts, and cy pres awards.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyHospital pricing varies based on services provided

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

USC/Norris Cancer Hospital product offering

Product offering

Core offering

USC Norris Cancer Hospital, part of the USC Norris Comprehensive Cancer Center, delivers inpatient and outpatient cancer care through a 60-bed hospital and multiple outpatient locations across Southern California. As an NCI-designated Comprehensive Cancer Center, it also runs more than 150 active oncology clinical trials and operates five interdisciplinary research programs backed by shared resource cores (flow cytometry, liquid biopsy, molecular genomics, translational pathology, data science, population research, and preclinical models).

Product overview

USC Norris Comprehensive Cancer Center is an NCI-designated Comprehensive Cancer Center that operates as a single integrated platform offering cancer research, clinical care, clinical trials, and community outreach. The organization provides five major research programs (Tumor Immunology & Microenvironment, Epigenetic Regulation in Cancer, Translational and Clinical Sciences, Cancer Epidemiology, Cancer Control Research) supported by eight shared resource cores (Flow Cytometry, Liquid Biopsy, Molecular Genomics, Translational Pathology, Data Science, Population Research, Preclinical Models, Glass Wash/Autoclave). Patient care services are delivered through Keck Medicine of USC, while specialized programs include the Cancer Navigator, Center for Cancer Drug Development, Breast Cancer Survivorship Program, AYA Cancer Program, and NON-CHE Program for community health education. Additional support services include biorepositories, the Jennifer Diamond Cancer Resource Library, and various community wellness programs like Trojans Adelante.

Differentiator

Problem solved

Functional benefit

Products and services

  • Patient Care Services Personalized, patient-centered cancer care including treatment, diagnostics, and survivorship support delivered through the 60-bed USC Norris Cancer Hospital and outpatient locations for individual cancer patients.
  • Clinical Trials Program

Quantifiable outcome

  • 48 years as an NCI-designated comprehensive cancer center
  • +2 more outcomes

Companies that use USC/Norris Cancer Hospital

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles4 records

USC/Norris Cancer Hospital technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

USC/Norris Cancer Hospital partnerships and signals

Strategic signal

Partnerships

15 partnerships are on record, tiered major, minor and core.

  • Tower Cancer Research FoundationmajorStrategic or Co-development Partner · 1 January 2019Partnered in organizing the inaugural bilingual Community Cancer Conference on Innovative Research and Precision Oncology Treatments.
  • Lippin FamilymajorStrategic or Co-development Partner · 1 January 2019Partnered with USC Norris and Tower Cancer Research Foundation for the Community Cancer Conference on Innovative Research and Precision Oncology Treatments.
  • Lazarex Cancer FoundationmajorStrategic or Co-development Partner · 1 January 2019Community partner for the inaugural Community Cancer Conference supporting underserved patient community in Los Angeles.
  • American Heart AssociationmajorStrategic or Co-development Partner · 1 January 2019Partner in the USC Adelante/A Tu Salud Food Distribution Partnership Program addressing food insecurity for patients and community members.
  • YMCAmajorStrategic or Co-development Partner · 1 January 2019Partner in food distribution program providing food 5 days a week at YMCA Weingart in Boyle Heights for individuals facing food insecurity.
  • White Memorial HospitalminorStrategic or Co-development Partner · 1 January 2019Partner in expanded food distribution program during COVID-19 pandemic.
  • Clinica RomerominorStrategic or Co-development Partner · 1 January 2019Partner in expanded food distribution program during COVID-19 pandemic.
  • Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity CentercoreStrategic or Co-development Partner · 1 January 2018NCI-funded partnership between USC Norris, University of Florida, and Florida A&M University addressing cancer disparities with focus on prostate and pancreatic cancer among African Americans and Latinos. Trains URM faculty and graduate/post-doctoral trainees.
  • Clinica Oscar RomerocoreStrategic or Co-development Partner · 1 January 2016Community health partner for the C4-SPA4 Promotores Outreach Program providing free cancer education to approximately 600 residents annually.
  • Children's Hospital Los AngelescoreStrategic or Co-development Partner · 1 January 2013Collaborative partner in the Adolescent and Young Adult (AYA) Cancer Program, representing a collaboration between USC Norris, USC Norris Cancer Hospital, CHLA, and Los Angeles County Hospital.
  • Los Angeles County HospitalcoreStrategic or Co-development Partner · 1 January 2013Partner in the Adolescent and Young Adult (AYA) Cancer Program collaboration.
  • Ralph Lauren Center for Cancer PreventioncoreStrategic or Co-development PartnerCommunity-based cancer prevention center providing services to local communities as part of USC Norris outreach efforts.
  • ORIEN (Oncology Research Information Exchange Network)coreStrategic or Co-development PartnerCollaborative network of cancer research institutions sharing data and accelerating discoveries through coordinated research efforts.
  • Jennifer Diamond FoundationmajorStrategic or Co-development PartnerFoundation that funded the Patient Education and Outreach Center and Jennifer Diamond Cancer Resource Library at USC Norris, created to help others by providing resources to cancer patients and families.
  • National Outreach Network (NON)coreStrategic or Co-development PartnerNCI-supported program providing community health educators to deliver HPV education and clinical trial awareness workshops in Los Angeles County.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

USC/Norris Cancer Hospital competitors and assessment

Company assessment

Direct peers

  • City of Hope Comprehensive Cancer Center: NCI-designated Comprehensive Cancer Center with a major hospital, clinical trials, and research programs in the greater Los Angeles market — a direct competitor for patients, faculty, and trial sponsorship.
  • Stanford Cancer Institute: NCI-designated Comprehensive Cancer Center at Stanford with comparable academic medical-center structure, translational research programs, and clinical trial portfolio in California.
  • UCLA Jonsson Comprehensive Cancer Center: NCI-designated Comprehensive Cancer Center at UCLA, also located in Los Angeles and offering overlapping research programs, clinical trials, and inpatient/outpatient cancer services to a similar patient base in Southern California.
  • Roswell Park Comprehensive Cancer Center: NCI-designated Comprehensive Cancer Center operating a dedicated cancer hospital, research programs, and clinical trials; a structurally similar standalone academic cancer center for benchmarking scale and operations.
  • Northwestern Medicine Lou and Jean Malnati Brain Tumor Institute / Robert H. Lurie Comprehensive Cancer Center: NCI-designated Comprehensive Cancer Center at Northwestern; the CAO at USC Norris previously held senior academic administration positions at Northwestern, providing a direct operational and structural comparison point.
  • UC San Diego Moores Cancer Center: NCI-designated Comprehensive Cancer Center at UC San Diego with parallel research programs (immunology, genomics), clinical trials, and community outreach; the CAO at USC Norris previously held a senior role here.

Broad incumbents

  • Fred Hutchinson Cancer Center: NCI-designated cancer center affiliated with UW Medicine with major research programs in immunotherapy and translational sciences; comparable in research depth and clinical trial pipeline.
  • Memorial Sloan Kettering Cancer Center: Largest standalone NCI-designated cancer center with an extensive clinical trials portfolio and specialty oncology hospital; a national benchmark peer for translational research and clinical operations.
  • Cedars-Sinai Medical Center (Samuel Oschin Cancer Center): Large Los Angeles academic medical center operating a cancer program with hospital beds, outpatient oncology, and clinical research; competes for the same regional patient base across a broader service portfolio.
  • MD Anderson Cancer Center: NCI-designated Comprehensive Cancer Center with the largest cancer hospital bed count and trial volume in the US; senior Norris leadership previously worked at MD Anderson, and it represents the scale benchmark.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

USC/Norris Cancer Hospital social profiles

Digital presence

USC/Norris Cancer Hospital compliance and trust

Trust signal

Compliance1 record

USC/Norris Cancer Hospital financial estimates

Financial estimate

Revenue estimate

Valuation estimate

USC/Norris Cancer Hospital leadership team

Management profile

Number of profiles

Profiles11 records

USC/Norris Cancer Hospital funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

USC/Norris Cancer Hospital M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about USC/Norris Cancer Hospital

What does USC/Norris Cancer Hospital do?

USC Norris Cancer Hospital, part of the USC Norris Comprehensive Cancer Center, delivers inpatient and outpatient cancer care through a 60-bed hospital and multiple outpatient locations across Southern California. As an NCI-designated Comprehensive Cancer Center, it also runs more than 150 active oncology clinical trials and operates five interdisciplinary research programs backed by shared resource cores (flow cytometry, liquid biopsy, molecular genomics, translational pathology, data science, population research, and preclinical models).

Is USC/Norris Cancer Hospital a public or private company?

USC/Norris Cancer Hospital is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was USC/Norris Cancer Hospital founded?

USC/Norris Cancer Hospital was founded in 1973. It employs 101 to 250 people.

Where is USC/Norris Cancer Hospital based?

USC/Norris Cancer Hospital is headquartered in Los Angeles, United States, in the North America region.

How does USC/Norris Cancer Hospital make money?

Three revenue lines are on record. Patient Care Services are the primary driver. The others are research Grants and Funding and philanthropic Donations.

Who are USC/Norris Cancer Hospital's main competitors?

Direct peers on record are City of Hope Comprehensive Cancer Center, Stanford Cancer Institute, UCLA Jonsson Comprehensive Cancer Center, Roswell Park Comprehensive Cancer Center, Northwestern Medicine Lou and Jean Malnati Brain Tumor Institute / Robert H. Lurie Comprehensive Cancer Center and UC San Diego Moores Cancer Center. Broad incumbents are Fred Hutchinson Cancer Center, Memorial Sloan Kettering Cancer Center, Cedars-Sinai Medical Center (Samuel Oschin Cancer Center) and MD Anderson Cancer Center.

Does USC/Norris Cancer Hospital have an API?

No public API is recorded for USC/Norris Cancer Hospital.

What industry is USC/Norris Cancer Hospital in?

USC/Norris Cancer Hospital's product category is Oncology Hospital Services. Its primary akta.pro industry code is HLAFAHAC, Oncology & Cancer Specialty Hospitals, with a secondary code of HLAFAAAM, Hospital-Integrated Cancer Centers (Acute Oncology Programs). Its NAICS code is 622310 and its SIC code is 8060.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Innovation News Network$7.5m NIH research to study how PFAS exposure contributes to liver and endometrial cancerResearchers at USC's Keck School of Medicine and Norris Comprehensive Cancer Center received $7.5 million in NIH funding for two five-year R01 grants examining PFAS exposure and liver and endometrial cancer. The endometrial project, awarded $4.1 million in June 2026, will study pre-diagnostic blood samples from 600 cancer cases and 1,200 controls, while the liver cancer study received $3.4 million in March 2026.News-MedicalNIH grants support research on whether PFAS exposure increases risk of liver and endometrial cancersResearchers at USC's Keck School of Medicine and Norris Comprehensive Cancer Center received two NIH R01 grants totaling $7.5 million to study whether PFAS exposure raises the risk of liver and endometrial cancers. The first, a $3.4 million five-year award in March 2026, uses the Multiethnic Cohort Study and liver spheroids; the second, $4.1 million, examines 600 endometrial cancer cases and 1,200 controls.KeckmedicineUSC Norris Comprehensive Cancer Center opens state-of-the-art Newport Beach radiation oncology and imaging centerUSC Norris Comprehensive Cancer Center, part of Keck Medicine of USC, has opened a new radiation oncology and imaging center in Newport Beach, California. The facility is the first in Orange County to offer biology-guided radiation therapy using the RefleXion X1 system, developed by Reflexion Medical. This expansion was completed in collaboration with Advanced Radiotherapy Technologies (ART Health), a division of Kingsbarn Realty Capital.UscHow to Improve Access to Health Care: Issues & Potential SolutionsThe article analyzes barriers to health care access in the United States, including high costs, transportation deficits, and implicit bias, while proposing solutions such as Medicaid expansion, telehealth, and mobile clinics. It highlights that 30% of Americans cite cost as a barrier and notes disparities in outcomes for minority populations. The piece concludes by promoting an executive Master of Health Administration program at USC as a pathway for leaders to address these systemic issues.UscUSC Norris collaborates with Auransa on clinical trial of new targeted treatment for liver cancer and other solid tumorsUSC Norris Comprehensive Cancer Center has entered a collaboration with Auransa Inc. to conduct a phase 1 clinical trial for AU409, a novel drug targeting liver cancer and other solid tumors. The trial, led by Dr. Anthony El-Khoueiry, aims to evaluate the drug's unique mechanism of interrupting cancer cell protein production in patients with advanced hepatocellular carcinoma or liver-dominant metastatic disease. This partnership leverages Auransa's AI-driven drug discovery platform alongside USC's clinical research capabilities to address high unmet needs in oncology.GlobeNewswirePOP UP “HUBS” PROVIDE A LIFELINE TO CANCER CARE FOR UNDERSERVED COMMUNITIESLazarex Cancer Foundation and USC Norris Comprehensive Cancer Center established Lazarex Cancer Wellness HUBs in underserved Los Angeles communities. The pop-up hubs, funded by an Amgen grant, offer cancer education, screening, and clinical trial information. They use existing community facilities and employ local staff to provide culturally tailored services.PR NewswireUSC Norris Launches Breakthrough Program to Increase Diversity in Cancer Clinical TrialsUSC Norris Comprehensive Cancer Center and Lazarex Cancer Foundation launched the IMPACT program to remove financial barriers for cancer patients participating in clinical trials. The initiative, sponsored by Amgen and involving UCSF Helen Diller Comprehensive Cancer Center, provides travel reimbursements and educational outreach to increase enrollment and diversity. A pilot at Massachusetts General Hospital demonstrated a 29% improvement in patient enrollment and doubled minority participation.YouTube"The Case Against Sugar," Gary Taubes, Investigative Science & Health JournalistGary Taubes, co-founder of the Nutrition Science Initiative, will deliver the 7th Annual C. Everett Koop Distinguished Lecture on his book The Case Against Sugar, co-sponsored by the C. Everett Koop Institute, the Norris Cotton Cancer Center and the Nelson A. Rockefeller Center. He will address the sugar industry's influence on public policy and research, and the link between sugar, weight change, diabetes and chronic disease. The lecture was recorded April 25, 2018.UscFasting-like diet turns the immune system against cancerA USC-led study published in Cancer Cell demonstrates that a fasting-like diet combined with chemotherapy strips away immune protection for breast and skin cancer cells, making them more vulnerable to attack. This approach was shown to be as effective as water-only starvation while reducing side effects, potentially offering an inexpensive method to enhance immunotherapy effectiveness.